المقال
GlaxoSmithKline to inject £60m into HIV and Aids drugs in Africa
GSK will create a new Positive Action for Children Fund that will have access to £50m over the next 10 years, and has also granted Aspen Pharmacare, in which it acquired a 16pc stake in May, a royalty-free licence to develop a cheaper, generic version of its HIV treatment abacavir... MP David Borrow, chairman of the All Party Parliamentary Group on Aids, said he welcomed GSK's new commitments, but added: "GSK is taking positive steps, but they are broadly unilateral, which will limit their impact. We would like to see them work with Unitaid to create a patent pool which gives fair royalties for their patents." [also refers to Pfizer]